Dr. Gulcan Albayrak is a gynecology and women’s health specialist. She trained at Uludağ University Faculty of Medicine, Ankara Zekai Tahir Burak Women’s Health Training and Research Hospital, and the Harris Birthright Fetal Medicine Research Center in London. She has worked at Medicine Hospital, Private İlke Hospital, Private GOP Hospital, Ankara Çankaya Özel Hasvak Hospital, and Erzincan State Hospital. She also served as a specialist at Medcare Hospital, Dubai.
Her advanced training includes hysteroscopy (Sunrise Hospital, Kerala) and colposcopy (Istanbul University–Çapa). She also trained in non-hormonal menopause care (Exeltis, Madrid), MonaLisa Touch CO2 vaginal laser, genital aesthetics (ICC), and vulvar filler/PRP. She holds a Ministry of Health–approved mesotherapy certificate. She is a member of TJOD, TSRM, the Turkish-German Gynecology Association, EJD, ITO, and ESAG. Publications include “Reproductive outcome of septate uterus after hysteroscopic metroplasty” (Archives of Gynecology & Obstetrics, Vol. 26B, Issue 4, Oct 2003, ZaS-ZSZI) and a cervical rhabdomyosarcoma case report (poster, Antalya Congress).
ドクター・ヌリ・ジェイデリは、15年以上の経験を持つ婦人科・産科医です。イスタンブール大学医学部(1995年)およびイスタンブール大学チェッラーパシャ医学部(2002年)を卒業し、トルコ婦人科産科学会、トルコ婦人科腫瘍学会、外科感染症学会、およびAAGLの会員です。
Prof. Mesut Polat, MD. Obstetrics and Gynecology; Gynecologic Oncology. Expertise: gynecologic oncology; advanced and minimally invasive gynecologic surgery; high‑risk obstetrics; placenta accreta spectrum; medical and surgical management of postpartum hemorrhage.
Professor at Medipol Acıbadem District Hospital (2019–2025). Former obstetrics and gynecology specialist at Istanbul Medeniyet University Göztepe and Zeynep Kamil Hospitals. Administrative lead at Zeynep Kamil (2015–2016). Teaches undergraduate and postgraduate students. Co‑supervised theses in 2016. Member of the Turkish Society of Obstetrics and Gynecology.
Author of 19 international peer‑reviewed papers indexed in SCI, SCI‑Expanded, and SSCI. Topics include cesarean myomectomy, frozen section in endometrial cancer, urinary outcomes after hysterectomy, placenta percreta, and tamoxifen‑related uterine sarcoma. Presented at international congresses in 2016 and national congresses in 2015–2016. Awards include Certificates of Appreciation from the Republic of Türkiye Ministry of Health (2015, 2016).